Hemant Kumar Bid
Overview
Explore the profile of Hemant Kumar Bid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
615
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khurshid S, Montes M, Comiskey Jr D, Shane B, Matsa E, Jung F, et al.
NPJ Precis Oncol
. 2022 Jan;
6(1):1.
PMID: 35017650
Rhabdomyosarcoma (RMS) is an aggressive pediatric tumor with a poor prognosis for metastasis and recurrent disease. Large-scale sequencing endeavors demonstrate that Rhabdomyosarcomas have a dearth of precisely targetable driver mutations....
2.
Lopez G, Braggio D, Zewdu A, Casadei L, Batte K, Bid H, et al.
PLoS One
. 2017 Nov;
12(11):e0188859.
PMID: 29186204
Leiomyosarcoma (LMS) is a malignant soft tissue sarcoma (STS) with a dismal prognosis following metastatic disease. Chemotherapeutic intervention has demonstrated to have modest clinical efficacy with no curative potential in...
3.
Xiao H, Bid H, Chen X, Wu X, Wei J, Bian Y, et al.
PLoS One
. 2017 Jul;
12(7):e0180297.
PMID: 28672024
Interleukins-6 (IL-6)/GP130 signaling pathway represents a promising target for cancer therapy due to its critical role in survival and progression of multiple types of cancer. We have identified Bazedoxifene, a...
4.
Bixel K, Saini U, Bid H, Fowler J, Riley M, Wanner R, et al.
Int J Cancer
. 2017 Jun;
141(9):1856-1866.
PMID: 28646535
Advanced ovarian clear cell carcinoma (OCCC) carries a very poor prognosis in large part secondary to the extremely high rate of resistance to standard platinum and taxane chemotherapy. Signal transducer...
5.
6.
Saini U, Naidu S, ElNaggar A, Bid H, Wallbillich J, Bixel K, et al.
Oncogene
. 2016 Jun;
36(2):168-181.
PMID: 27292260
Although activation of the STAT3 pathway has been associated with tumor progression in a wide variety of cancer types (including ovarian cancer), the precise mechanism of invasion and metastasis due...
7.
Lopez G, Song Y, Lam R, Ruder D, Creighton C, Bid H, et al.
Mol Cancer Res
. 2015 Sep;
14(1):35-43.
PMID: 26396249
Unlabelled: Epithelioid sarcoma is a rare neoplasm uniquely comprised of cells exhibiting both mesenchymal and epithelial features. Having propensity for local and distant recurrence, it poses a diagnostic dilemma secondary...
8.
Lopez G, Bill K, Bid H, Braggio D, Constantino D, Prudner B, et al.
PLoS One
. 2015 Jul;
10(7):e0133302.
PMID: 26200462
Introduction: HDAC isoform-specific inhibitors may improve the therapeutic window while limiting toxicities. Developing inhibitors against class I isoforms poses difficulties as they share high homology among their catalytic sites; however,...
9.
10.
Xiao H, Bid H, Jou D, Wu X, Yu W, Li C, et al.
J Biol Chem
. 2014 Oct;
290(6):3418-29.
PMID: 25313399
Signal transducers and activators of transcription 3 (STAT3) signaling is persistently activated and could contribute to tumorigenesis of medulloblastoma. Numerous studies have demonstrated that inhibition of the persistent STAT3 signaling...